Distal Thrombectomy - Wednesday Webinar Series
12pm-1pm EST / 6pm-7pm CET
Sept 16
SESSION 1 - DISTAL OCCLUSION PROPERTIES
Moderator: Rishi Gupta, MD, WellStar Health System, Atlanta, Georgia, USA
Introduction of Distal Thrombectomy Webinar Series
Rishi Gupta, MD, WellStar Health System, Atlanta, Georgia, USA
What is a DVO? Definitions, frequency, and epidemiology
Clot composition of distal occlusions
David Liebeskind, MD, UCLA Health, Los Angeles, California, USA
What is a DVO? Tissue at risk and clinical consequences
Distal posterior vs. anterior circulations
David Liebeskind, MD, UCLA Health, Los Angeles, California, USA
The use of Artificial Intelligence to help screen for potential distal occlusions, CTA, CTP
Ameer Hassan, DO, Valley Baptist Medical Center, Harlingen, Texas, USA
12pm-1pm EST
6pm-7pm CET
SESSION 2 - MEASUREMENT AND TRIAL DESIGN
Moderator: Kyriakos Lobotesis, MD, Imperial College Healthcare NHS Trust, London, UK
Clinical trial design: time window and imaging criteria for patient selection
Jeffrey Saver, MD, UCLA Health, Los Angeles, California, USA
Defining efficacy parameters of distal thrombectomy (grading systems and scales)
Jens Fiehler, MD, University Medical Center Hamburg-Eppendorf, Germany
Challenges in measuring efficacy (rehab experience)
Samir Belagaje, MD, Emory University Hospital, Atlanta, Georgia, USA
Sept 30
12pm-1pm EST
6pm-7pm CET
SESSION 3 - IMAGING AND TREATMENT CONSIDERATIONS
Moderator: Markus Holtmannspötter, MD, South Nuremberg Hospital, Nuremberg, Germany
Distal image pattern recognition and selection/Automatic distal vessel occlusion detection
Shalini Amukotuwa, MD, Monash Health, Melbourne, Australia
Distal MT criteria/ How pattern selection impacts outcomes
Jeremy Heit, MD, Stanford Health Care, Stanford, California, USA
Identify criteria for clot busting drug vs. DMVO MT
New clinical trials and impact of IV-tPA and thrombolytics
David Fiorella, MD, Stony Brook Neuroscience Institute, Stony Brook, New York, USA
Safety and efficacy of IAT after incomplete LVO mechanical thrombectomy
Urs Fischer, MD, University of Bern, Bern, Switzerland
Oct 14
12pm-1pm EST
6pm-7pm CET
Oct 28
SESSION 4 - CLINICAL WORKFLOW
Moderator: Sebastian Fischer, MD, University Hospital Knappschaftskrankenhaus Bochum, Germany
Patient journey from spoke hospital to distal MT treatment—what does workflow look like now
Nima Aghaebrahim, MD, Baptist Medical Center, Jacksonville, Florida, USA
Patient assessment—checkpoints for triage or transfer for MT and future of distal MT workflow impact
Pascal Jabbour, MD, Jefferson Hospital for Neuroscience, Philadelphia, Pennsylvania, USA
Direct to Angio—implications for distal occlusions: post-tpa clot migration in patient transfer and direct-to-angio without vessel imaging
Ashutosh Jadhav, MD, Barrow Brain and Spine, Phoenix, Arizona, USA
Role of novel devices (future impact) vs. current tools (MT now)
Rene Chapot, MD, Alfried Krupp Krankenhaus, Essen, Germany
1pm-2pm EST
6pm-7pm CET
* Tigertriever 13 and Tigertriever XL Devices are not FDA cleared in the USA